Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dingemans, A.-M.C., Früh, M., Ardizzoni, A., Besse, B., Faivre-Finn, C., Hendriks, L.E., Lantuejoul, S., Peters, S., Reguart, N., Rudin, C.M., De Ruysscher, D., Van Schil, P.E., Vansteenkiste, J., Reck, M.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study
De Ruysscher, D., Botterweck, A., Dirx, M., Pijls-Johannesma, M., Wanders, R., Hochstenbag, M., Dingemans, A.-M. C., Bootsma, G., Geraedts, W., Simons, J., Pitz, C., Lambin, P.
Published in Annals of oncology (01.01.2009)
Published in Annals of oncology (01.01.2009)
Get full text
Journal Article
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study
Hendriks, L.E, Derks, J.L, Postmus, P.E, Damhuis, R.A, Houben, R.M.A, Troost, E.G.C, Hochstenbag, M.M, Smit, E.F, Dingemans, A.-M.C
Published in European journal of cancer (1990) (01.11.2015)
Published in European journal of cancer (1990) (01.11.2015)
Get full text
Journal Article
EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?
Hendriks, L.E.L, Smit, E.F, Vosse, B.A.H, Mellema, W.W, Heideman, D.A.M, Bootsma, G.P, Westenend, M, Pitz, C, de Vries, G.J, Houben, R, Grünberg, K, Bendek, M, Speel, E.-J.M, Dingemans, A.-M.C
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Get full text
Journal Article
A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)
Dingemans, A.-M. C., Groen, H.J.M., Herder, G.J.M., Stigt, J.A., Smit, E.F., Bahce, I., Burgers, J.A., van den Borne, B.E.E.M., Biesma, B., Vincent, A., van der Noort, V., Aerts, J.G.
Published in Annals of oncology (01.11.2015)
Published in Annals of oncology (01.11.2015)
Get full text
Journal Article
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging
Dingemans, A.-M. C., de Langen, A.J., van den Boogaart, V., Marcus, J.T., Backes, W.H., Scholtens, H.T.G.M., van Tinteren, H., Hoekstra, O.S., Pruim, J., Brans, B., Thunnissen, F.B., Smit, E.F., Groen, H.J.M.
Published in Annals of oncology (01.03.2011)
Published in Annals of oncology (01.03.2011)
Get full text
Journal Article
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study
AERTS, J. G, CODRINGTON, H, LANKHEET, N. A. G, BURGERS, S, BIESMA, B, DINGEMANS, A. -M. C, VINCENT, A. D, DALESIO, O, GROEN, H. J. M, SMIT, E. F
Published in Annals of oncology (01.11.2013)
Published in Annals of oncology (01.11.2013)
Get full text
Journal Article
Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
de Jong, E.E.C., Sanders, K.J.C., Deist, T.M., van Elmpt, W., Jochems, A., van Timmeren, J.E., Leijenaar, R.T.H., Degens, J.H.R.J., Schols, A.M.W.J., Dingemans, A.-M.C., Lambin, P.
Published in European journal of cancer (1990) (01.10.2019)
Published in European journal of cancer (1990) (01.10.2019)
Get full text
Journal Article
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer
van der Wekken, A J, Pelgrim, R, 't Hart, N, Werner, N, Mastik, M F, Hendriks, L, van der Heijden, E H F M, Looijen-Salamon, M, de Langen, A J, Staal-van den Brekel, J, Riemersma, S, van den Borne, B E, Speel, E J M, Dingemans, A-M C, Hiltermann, T J N, van den Berg, A, Timens, W, Schuuring, E, Groen, H J M
Published in Clinical cancer research (01.08.2017)
Published in Clinical cancer research (01.08.2017)
Get full text
Journal Article
Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Willemsen, A C H, Degens, J H R J, Baijens, L W J, Dingemans, A-M C, Hoeben, A, Hoebers, F J P, De Ruysscher, D K M, Schols, A M W J
Published in Frontiers in nutrition (Lausanne) (26.11.2020)
Published in Frontiers in nutrition (Lausanne) (26.11.2020)
Get full text
Journal Article
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients
De Ruysscher, D, Dehing, C, Bremer, R-H, Bentzen, SM, Koppe, F, Pijls-Johannesma, M, Harzée, L, Minken, A, Wanders, R, Hochstenbag, M, Dingemans, A-M, Boersma, L, van Haren, E, Geraedts, W, Pitz, C, Simons, J, Wouters, BG, Rosier, J-F, Lambin, P
Published in Annals of oncology (01.05.2007)
Published in Annals of oncology (01.05.2007)
Get full text
Journal Article
115PD Brain metastases (BM) development after chemoradiation (CRT) for stage III non-small cell lung cancer (NSCLC): Does the type of chemotherapy matter?
Hendriks, L., Brouns, A., Amini, M., Uyterlinde, W., Wijsman, R., Biesma, B., Stigt, J., Ruysscher, D. De, van den Heuvel, M., Dingemans, A.-M.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
158P PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel–carboplatin–bevacizumab with or without nitroglycerin
de Jong, E.E.C., Van Elmpt, W., Leijenaar, R.T.H., Groen, H., Smit, E., Boellaard, R., Van der Noort, V., Troost, E.G.C., Lambin, P., Dingemans, A.-M.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Passaro, A., Leighl, N., Blackhall, F., Popat, S., Kerr, K., Ahn, M.J., Arcila, M.E., Arrieta, O., Planchard, D., de Marinis, F., Dingemans, A.M., Dziadziuszko, R., Faivre-Finn, C., Feldman, J., Felip, E., Curigliano, G., Herbst, R., Jänne, P.A., John, T., Mitsudomi, T., Mok, T., Normanno, N., Paz-Ares, L., Ramalingam, S., Sequist, L., Vansteenkiste, J., Wistuba, I.I., Wolf, J., Wu, Y.L., Yang, S.R., Yang, J.C.H., Yatabe, Y., Pentheroudakis, G., Peters, S.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J., Besse, B., Aix, S. Ponce, Callejo, A., Al-Rabi, K., Bernabe, R., Greillier, L., Majem, M., Reguart, N., Monnet, I., Cousin, S., Garrido, P., Robinet, G., Garcia Campelo, R., Madroszyk, A., Mazières, J., Curcio, H., Wasąg, B., Pretzenbacher, Y., Fournier, B., Dingemans, A.-M.C., Dziadziuszko, R.
Published in Annals of oncology (01.05.2023)
Published in Annals of oncology (01.05.2023)
Get full text
Journal Article
Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
Hermans, B C M, Derks, J L, Groen, H J M, Stigt, J A, van Suylen, R J, Hillen, L M, van den Broek, E C, Speel, E J M, Dingemans, A-M C
Published in Endocrine Connections (01.12.2019)
Published in Endocrine Connections (01.12.2019)
Get full text
Journal Article
Diagnostic Validity of the Eppendorf Schizophrenia Inventory (ESI): A Self-Report Screen for Ultrahigh Risk and Acute Psychosis
Niessen, Maurice A. J, Dingemans, Peter M. A. J, van de Fliert, Reinaud, Becker, Hiske E, Nieman, Dorien H, Linszen, Don
Published in Psychological assessment (01.12.2010)
Published in Psychological assessment (01.12.2010)
Get more information
Journal Article
Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
Xander, N.S.H., Leeneman, B., Dingemans, A.-M.C., Fiets, W.E., de Jong, W.K., Uyl, N.E.M., Wymenga, A.N.M., Reyners, A.K.L., Uyl-de Groot, C.A.
Published in European journal of cancer (1990) (01.09.2024)
Published in European journal of cancer (1990) (01.09.2024)
Get full text
Journal Article
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer
Pruis, M.A., Geurts-Giele, W.R.R., von der, Thüsen J.H., Meijssen, I.C., Dinjens, W.N.M., Aerts, J.G.J.V., Dingemans, A.M.C., Lolkema, M.P., Paats, M.S., Dubbink, H.J.
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2020)
Get full text
Journal Article